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Effects of a 4-week intervention using semi-custom insoles on perceived pain and 1 
patellofemoral loading in targeted subgroups of recreational runners with 2 
patellofemoral pain. 3 
Abstract 4 
OBJECTIVE: Explore the effects of a 4-week intervention using semi-custom insoles in 5 
recreational runners with patellofemoral pain.  6 
DESIGN: Mixed methods 7 
PARTICIPANTS:  Seventeen (10 males and 7 females) recreational runners. 8 
SETTING: Laboratory 9 
OUTCOME MEASUREMENTS: Participants were separated into specific subgroups, then 10 
provided with a pair of semi-custom insoles, for a period of 4-weeks. Lower extremity 11 
kinetics/kinematics during running at 4.0 m/s were obtained. In addition, knee pain was 12 
examined using the Knee injury and Osteoarthritis Outcome Score-Patellofemoral scale 13 
(KOOS-PF). Data were collected before and after wearing the insoles for 4-weeks.  14 
RESULTS: Significant improvements were shown for KOOS-PF in both subgroups (strong: 15 
(pre)=63.84 & (post)=71.49 and weak and tight: (pre)=53.03 & (post)=72.73), although only 16 
improvements in the weak and tight group exceeded the minimum clinically important 17 
difference (MCID). In addition, significant reductions in peak patellofemoral stress were 18 
shown in both subgroups (strong: (pre)=6.82 & (post)=6.39KPa/BW and weak and tight: 19 
(pre)=7.66 & (post)=6.28KPa/BW), although only reductions in the weak and tight group 20 
exceeded the MCID. 21 
CONCLUSIONS: Semi-custom insoles may be a mechanism to reduce patellofemoral pain 22 
symptoms in recreational runners from the weak and tight subgroup. It is proposed that this 23 
improvement was mediated through reductions in patellofemoral loading in this subgroup. 24 
 25 
Keywords: patellofemoral pain; patellofemoral loading; subgrouping; insoles 26 
 27 
Introduction 28 
Recreational running is an extremely popular physical and leisure modality, known to 29 
provide a plethora of physiological and psychological benefits (Lee et al., 2014). Over 2-30 
million people in the UK utilize running as a regular mode of exercise (Sport England, 2014). 31 
However, despite the clear physical benefits mediated by running, it is also known to be 32 
associated with a high incidence of chronic pathologies. Over the course of one-year as many 33 
as 80 % of runners will experience an overuse injury as a consequence of their training (Van 34 
Gent et al., 2007).  35 
 36 
Patellofemoral pain is the most common chronic pathology in runners (Taunton et al., 2002), 37 
which typically manifests as retropatellar or diffuse peripatellar pain, aggravated by activities 38 
such as running that frequently load the joint (Crossley et al., 2016). Elevated patellofemoral 39 
joint stress, which is a reflection of the patellofemoral joint reaction force divided by the 40 
patellofemoral contact area, is commonly accepted as a key aetiological factor in the 41 
development of patellofemoral pain syndrome (Farrokhi et al., 2011).  42 
 43 
The long term prognosis for those who present with patellofemoral pain is poor, with 44 
between 71-91 % all patients experiencing ongoing symptoms up to 20 years following 45 
diagnosis (Nimon et al., 1998). Female recreational runners are 2-3 times more likely to 46 
suffer from patellofemoral pain in comparison to males (Robinson & Nee, 2007), owing to 47 
increased dynamic knee abduction (Malinzak et al., 2001; Ford et al., 2003; Sakaguchi et al., 48 
2014), hip internal rotation (Lephart et al., 2002; Decker et al., 2003), hip adduction 49 
(Sakaguchi et al., 2014), knee valgus moment (Sigward & Powers, 2005) and patellofemoral 50 
stress (Sinclair & Selfe, 2015), as well as decreased dynamic measures of knee flexion angle 51 
(Malinzak et al., 2001; Lephart et al., 2002), hip abductor (Sugimoto et al., 2014) and 52 
quadriceps strength (Lephart et al., 2002). Importantly, those who experience patellofemoral 53 
symptoms may later present with radiographic evidence of osteoarthritis at this joint (Thomas 54 
et al., 2010). Pain symptoms force many runners to reduce or even end their participation in 55 
running activities (Blond & Hansen, 1998), and many individuals with patellofemoral pain 56 
develop associated psychological disorders including mental distress and self-perceived 57 
health (Jensen et al., 2005); pain-related fear, low self-efficacy and fear of the future (Smith 58 
et al., 2018); kinesiophobia, depression and catastrophizing (Maclachlan et al., 2018). 59 
 60 
As a consequence of the high incidence of patellofemoral pain, a significant range of 61 
conservative treatment modalities have been explored in biomechanical and clinical 62 
literature; including exercise therapy, taping, bracing, insoles, soft tissue manipulation and  63 
acupuncture (Smith et al., 2017). Pain is the key clinical symptom associated with 64 
patellofemoral syndrome, thus the attenuation of pain through conservative modalities is of 65 
considerable interest to both clinicians and researchers alike. Insoles utilized by runners 66 
typically feature a contoured medial arch profile, and offer a mechanism by which lower 67 
extremity joint loading can be altered.  68 
 69 
The acute effects of foot insoles on the kinetics and kinematics of running are well 70 
documented, but there is currently a paucity of research investigating biomechanical 71 
adaptations over time, or the effectiveness of insoles for the treatment of patellofemoral pain 72 
symptoms. Two studies are however of note. Collins et al., (2008) examined the efficacy of 73 
foot orthoses, flat inserts and multimodal physiotherapy in patients with clinically diagnosed 74 
patellofemoral pain. Their results showed that all three treatments mediated significant and 75 
clinically meaningful improvements in pain symptoms. Eng and Pierrynowski, (1993) 76 
assigned a group of adolescent female patients with patellofemoral pain to either: a control 77 
who undertook an exercise program, or a treatment group who were provided with soft 78 
insoles in addition to participating in the exercise program. Their findings showed that both 79 
the treatment and control groups exhibited significant reductions in pain, but that 80 
improvements in the treatment group were significantly greater than those in the control 81 
group. Both studies indicate that soft insoles may be beneficial in the treatment of 82 
patellofemoral pain symptoms for patients, but whether these findings also apply to 83 
recreational runners with patellofemoral pain symptoms is unknown.  84 
 85 
Different factors may predispose recreational runners compared to patients to the 86 
development and therefore treatment of patellofemoral pain symptoms, due to their 87 
physiological differences. Selfe et al., (2016) recently identified three subgroups of patients 88 
with patellofemoral pain (‘strong’, ‘weak and tight’ and ‘weak and pronated foot’) using six 89 
low cost, simple clinical assessment tests that can be applied in routine practice. This initial 90 
study suggested that developing a strategy to target specific interventions for each subgroup 91 
may ultimately lead to improved patient outcomes. The current study aimed to explore the 92 
effects of a 4-week intervention using semi-custom foot insoles on pain symptoms and 93 
patellofemoral loading in subgroups of recreational runners.  94 
 95 
Methods 96 
Participants 97 
Seventeen participants (10 male and 7 female), volunteered to take part. Participants were 98 
invited to attend the laboratory if they suffered from self-reported knee pain exacerbated by 99 
their running training. Specific diagnosis of patellofemoral was made in accordance with the 100 
recommendations of Crossley et al., (2002). Participants were excluded from the study if 101 
there was evidence of any other knee pathology or they had previously undergone surgery on 102 
the patellofemoral joint. Furthermore, participants who had exhibited symptoms for less than 103 
3 months were also excluded, as were those aged 50 or above to reduce the likelihood of pain 104 
being caused by degenerative joint disease. Written informed consent was provided in 105 
accordance with the declaration of Helsinki. The procedure was approved by the Universities 106 
Science, Technology, Engineering, Medicine and Health ethics committee, with the reference 107 
STEMH 424. 108 
 109 
Procedure 110 
Participants attended the laboratory on two occasions. On the first occasion the participants 111 
were assessed using the six clinical tests described by Selfe et al. (2016) on their affected 112 
limb only. These assessments involved two muscle strength tests (quadriceps and hip 113 
abductors), two muscle length tests (m. gastrocnemius and m. rectus femoris), one patellar 114 
mobility test, and one foot posture index test (Redmond et al., 2006). Based on this 115 
information participants were sub-grouped in accordance with Selfe et al. (2016) which 116 
revealed that participants belonged to either the ‘strong’ (N=11) or weak and tight (N=6) 117 
groups (Table 1). All other tests were completed on both occasions.  118 
 119 
@@@ TABLE 1 NEAR HERE @@@ 120 
 121 
Clinical tests 122 
Initially participants completed the Knee injury and Osteoarthritis Outcome Score-123 
Patellofemoral subscale (KOOS-PF) (Crossley et al., 2017) and Coop-Wonca questionnaires 124 
(Jensen et al., 2015), in order to assess self-reported knee pain and psychological wellbeing. 125 
Biomechanical data was then collected from the participants during running trials in their 126 
own footwear, as described below.  127 
 128 
Intervention 129 
Once the biomechanical and KOOS-PF data were obtained, participants were then provided 130 
with a pair of off-the-shelf insoles (Sole Control, Sole, Milton Keynes, UK) in their size. The 131 
insoles were made from ethylene-vinyl acetate and had a shore A 30 hardness rating. Because 132 
the participants from both subgroups did not exhibit an everted foot posture, the insoles did 133 
not feature any rearfoot posting. Participants were asked to wear the insoles for all of their 134 
running training for 4-weeks (Bolgla & Boling, 2011). To mould the insoles they were placed 135 
into a pre-heated oven (90 °C) for a duration of two minutes. The heated insoles were then 136 
placed inside the participants shoes. Participants were asked to stand upright without moving 137 
for two minutes to allow the process of moulding the insoles to the longitudinal arch profile 138 
of each participant, in accordance with manufacturer instructions. Insoles were placed inside 139 
both shoes although only the pathological side was examined. Participants were instructed to 140 
maintain their habitual training regime. They recorded the number of completed kilometers 141 
during the 4-week period prior to the intervention and again during the 4-week intervention 142 
period. Following the 4-week intervention participants returned to the laboratory where the 143 
complete protocol was repeated whilst wearing their insoles.  144 
 145 
Biomechanical tests 146 
Participants ran at a velocity of 4.0 m/s ±5%, striking an embedded piezoelectric force 147 
platform (Kistler, Kistler Instruments Ltd., Alton, Hampshire; length, width, height = 0.6 x 148 
0.4 x 0 m) with their affected limb. The force platform sampled at 1000 Hz. Running velocity 149 
was quantified using infrared timing gates, which were positioned 4 m apart. The stance 150 
phase of running was delineated as the duration over which > 20 N of vertical force was 151 
applied to the force platform. A successful trial was defined as one within the specified 152 
velocity range, where the foot made full contact with the force platform and where no 153 
evidence of gait modifications due to the experimental conditions were evident.  154 
 155 
Kinematics and ground reaction force (GRF) information were synchronously collected. 156 
Kinematic data were captured at 250 Hz via an eight camera motion analysis system 157 
(Qualisys Medical AB, Goteburg, Sweden). Dynamic calibration of the motion capture 158 
system was performed before each data collection session. 159 
 160 
Lower extremity segments were modelled in 6 degrees of freedom using the calibrated 161 
anatomical systems technique (Cappozzo et al., 1995), using a marker configuration utilized 162 
previously to quantify the effects of orthoses patellofemoral joint kinetics (Sinclair, 2018). To 163 
define the anatomical frames of the pelvis, thigh, shank and foot retroreflective markers were 164 
positioned onto the iliac crest, anterior superior iliac spine (ASIS), and posterior super iliac 165 
spine (PSIS). In addition, further markers were placed unilaterally onto the medial and lateral 166 
malleoli, greater trochanter, medial and lateral femoral epicondyles, calcaneus, first 167 
metatarsal and fifth metatarsal heads of the affected limb. Foot markers were positioned onto 168 
the upper of the participants’ shoes. Carbon-fiber tracking clusters comprising of four non-169 
linear retroreflective markers were positioned onto the thigh and shank segments. In addition 170 
to these the foot segments were tracked via the calcaneus, first metatarsal and fifth metatarsal, 171 
and the pelvic segment was tracked using the PSIS and ASIS markers. Static calibration trials 172 
were obtained with the participant in the anatomical position in order for the positions of the 173 
anatomical markers to be referenced in relation to the tracking clusters/markers. A static trial 174 
was conducted with the participant in the anatomical position in order for the anatomical 175 
positions to be referenced in relation to the tracking markers, following which those not 176 
required for dynamic data were removed. 177 
 178 
Processing 179 
Dynamic trials were digitized using Qualisys Track Manager in order to identify anatomical 180 
and tracking markers then exported as C3D files to Visual 3D (C-Motion, Germantown, MD, 181 
USA). All data were normalized to 100 % of the stance phase. GRF and kinematic data were 182 
smoothed using cut-off frequencies of 50 and 12 Hz with a low-pass Butterworth 4th order 183 
zero lag filter (Sinclair, 2014). Three dimensional kinematics of the knee and ankle were 184 
calculated using an XYZ cardan sequence of rotations (where X = sagittal plane; Y = coronal 185 
plane and Z = transverse plane). Three dimensional angular kinematic measures from the 186 
knee, ankle and tibia which were extracted for statistical analysis were 1) angle at footstrike, 187 
2) peak angle and 3) angular joint range of motion (ROM) from footstrike to peak angle. In 188 
addition the eversion/tibial internal rotation (EV/ TIR) ratio was calculated by dividing the 189 
eversion ROM by the tibial internal rotation ROM. Knee joint kinetics were computed using 190 
Newton-Euler inverse-dynamics and normalized to body mass. The peak knee adduction 191 
moment, knee adduction moment load rate (the peak increase in the adduction moment 192 
between adjacent data points) and knee adduction moment integral during the stance phase 193 
(using a trapezoidal function) were extracted. 194 
 195 
Patellofemoral loading during the stance phase of running was quantified using a model 196 
adapted from van Eijden et al., (1986), in accordance with the protocol of Wilson et al., 197 
(2015). The hamstring force was calculated using the hip extensor moment, hamstrings and 198 
gluteus maximus cross-sectional areas (Ward et al., 2009) and by fitting a 2nd order 199 
polynomial curve to the data of Nemeth & Ohlsen, (1985) who provided muscle moment 200 
arms at the hip as a function of hip flexion angle. The gastrocnemius force was calculated 201 
firstly by quantifying the ankle plantarflexor force, which was resolved by dividing the 202 
plantarflexion moment by the Achilles tendon moment arm. The Achilles tendon moment 203 
arm was calculated by fitting a 2nd order polynomial curve to the ankle plantarflexion angle 204 
in accordance with Self & Paine (2001). Plantarflexion force accredited to the gastrocnemius 205 
muscles was calculated via the cross-sectional area of this muscle relative to the triceps surae 206 
(Ward et al., 2009). 207 
 208 
The hamstring and gastrocnemius forces were multiplied by their estimated muscle moment 209 
arms to the knee joint in relation to the knee flexion angle (Spoor & van Leeuwen, 1992), and 210 
then added together to estimate the knee flexor moment. The derived knee flexor moment 211 
was added to the net knee extensor moment quantified using inverse dynamics were then 212 
summed and subsequently divided by the quadriceps muscle moment arm (van Eijden et al., 213 
1986), to obtain quadriceps force adjusted for co-contraction of the knee flexor musculature. 214 
Patellofemoral force was then quantified by multiplying the adjusted quadriceps force by a 215 
constant which was obtained by using the data of van Eijden et al., (1986). 216 
 217 
Finally, patellofemoral joint stress was quantified by dividing the patellofemoral force by the 218 
patellofemoral contact area. Patellofemoral contact areas were obtained by fitting a 219 
polynomial curve to the sex specific data of Besier et al., (2005), who estimated 220 
patellofemoral contact areas as a function of the knee flexion angle using MRI. All 221 
patellofemoral forces were normalized by dividing the net values by bodyweight (BW). From 222 
the above processing, peak patellofemoral force, and peak patellofemoral stress (KPa/BW) 223 
were extracted. Patellofemoral instantaneous load rate (BW/s) was also extracted by 224 
obtaining the peak increase in force between adjacent data points. 225 
 226 
The patellofemoral integral during the stance phase (quantified using a trapezoidal function) 227 
was also calculated and the total patellofemoral force per mile (BW·mile) was obtained by 228 
multiplying this parameter by the number of steps required to run a mile. The number of steps 229 
required to complete one mile was quantified using the step length (m), which was 230 
determined by taking the difference in the horizontal position of the foot centre of mass 231 
between the right and left legs at footstrike.  232 
 233 
Statistical analyses 234 
Descriptive statistics of means and standard deviations were obtained for each outcome 235 
measure. Shapiro-Wilk tests were used to screen the data for normality. Differences in 236 
running distance prior to and during the intervention were examined using a paired t-test. 237 
Differences in biomechanical and knee pain parameters were examined using 2 (PRE-POST 238 
INTERVENTION) x 2 (SUBGROUP) mixed ANOVA’s. Statistical significance was 239 
accepted at the P≤0.05 level. Effect sizes for all significant findings were calculated using 240 
partial Eta2 (pη2). Effect sizes were contextualized using the following guidelines; small = 241 
0.01, medium = 0.06  and large = 0.14 (Cohen, 1988). All statistical actions were conducted 242 
using SPSS v24.0 (SPSS Inc, Chicago, USA). In accordance with the recommendations of 243 
Crossley et al., (2017), the minimal clinically important difference (MCID) for the KOOS-PF 244 
scale was considered to be 16.4 points. For all of the other variables the MCID was 245 
considered to be 2.3 * the pooled standard error of measurement (Sinclair et al., 2018). 246 
 247 
Results 248 
Tables 2-5 present the knee pain, psychological wellbeing, patellofemoral loading and 249 
kinematic parameters obtained before and after the 4-week intervention.  250 
 251 
Running distance 252 
No significant difference (P>0.05) in running distance was observed. Participants completed 253 
17.26 ± 8.43 km of running training prior to the intervention and 17.19 ± 6.92 km during the 254 
intervention. 255 
 256 
Knee pain 257 
A significant PRE-POST INTERVENTION main effect (P<0.05, pη2 = 0.65) was observed 258 
for KOOS-PF pain symptoms with participants reporting significant improvements following 259 
the 4-week period. Importantly, the magnitude of the improvements exceeded the MCID in 260 
only the weak and tight sub-group (Table 2). There was no significant (P>0.05) main effect 261 
as a function of SUBGROUP (Table 2). 262 
 263 
Psychological wellbeing 264 
The Coop-Wonga questionnaire showed a significant PRE-POST INTERVENTION main 265 
effect of (P<0.05, pη2 = 0.48), with participants exhibiting significant improvements 266 
following the 4-week period. Importantly, the improvements in both subgroups exceeded the 267 
MCID. There was no significant (P>0.05) main effect as a function of SUBGROUP (Table 268 
2). 269 
 270 
@@@ TABLE 2 NEAR HERE @@@ 271 
 272 
Patellofemoral loading and knee moments 273 
Significant PRE-POST INTERVENTION main effects were observed for both peak 274 
patellofemoral force (P<0.05, pη2 = 0.41) and peak patellofemoral stress (P<0.05, pη2 = 0.42) 275 
with significant reductions being present following the 4-week period. Finally, a significant 276 
PRE-POST INTERVENTION main effect (P<0.05, pη2 = 0.37) was observed for 277 
patellofemoral force per mile, with significant reductions being present following the 4-week 278 
period. Importantly, in each of the aforementioned patellofemoral loading variables, the 279 
reductions exceeded the MCID in only the weak and tight sub-group (Table 3). There were 280 
no significant (P>0.05) main effects as a function of SUBGROUP for any of the 281 
patellofemoral loading variables (Table 3). 282 
 283 
Finally, for the knee adduction moment integral, a significant PRE-POST INTERVENTION 284 
main effect (P<0.05, pη2 = 0.32) was shown, with significant increases being present 285 
following the 4-week period (Table 3). Importantly, the increase in the knee adduction 286 
moment integral exceeded the MCID in only the weak and tight sub-group (Table 3). There 287 
was no significant (P>0.05) main effect as a function of SUBGROUP (Table 3). 288 
 289 
@@@ TABLE 3 NEAR HERE @@@ 290 
 291 
Joint kinematics 292 
For the knee sagittal angle at footstrike a significant PRE-POST INTERVENTION main 293 
effect (P<0.05, pη2 = 0.51) was shown, with the flexion angle being significantly reduced 294 
following the 4-week intervention. In addition, a significant PRE-POST INTERVENTION 295 
main effect (P<0.05, pη2 = 0.28) was shown for the magnitude of peak knee flexion, with 296 
peak flexion being significantly reduced following the 4-week period. Importantly, in each of 297 
the aforementioned joint kinematic variables, the reductions exceeded the MCID in only the 298 
weak and tight sub-group (Table 4). There were no significant (P>0.05) main effects as a 299 
function of SUBGROUP for any of the joint kinematic variables (Table 4). 300 
 301 
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 304 
Discussion 305 
This study explored the efficacy of semi-custom foot insoles in recreational runners with 306 
patellofemoral pain. The runners were categorized into previously identified subgroups (Selfe 307 
et al., 2016), which allowed the effects of the insoles to be considered by subgroup. To the 308 
authors knowledge this represents the first intervention study to explore the efficacy of 309 
insoles in recreational runners with patellofemoral pain using these targeted subgroups. Given 310 
the extremely high incidence of patellofemoral pain amongst runners, analyses of this nature 311 
may generate essential clinical information regarding conservative management of 312 
patellofemoral pain.  313 
 314 
The first key finding from the current investigation is that both patellofemoral pain symptoms 315 
and psychological wellbeing parameters were significantly improved in both subgroups as a 316 
function of the 4-week intervention using foot insoles. This observation concurs with those of 317 
Collins et al., (2008), who showed that insoles without medial posting produced significant 318 
and clinically meaningful improvements in pain symptoms in patients with patellofemoral 319 
pain. However, it should be noted that although a large effect size was revealed, the 320 
magnitude of the improvements in pain symptoms quantified via the KOOS-PF questionnaire 321 
only exceeded the MCID in the weak and tight group (Crossley et al., 2017). Of further 322 
importance is that participants average weekly running mileage remained consistent prior to 323 
and during the intervention period, indicating that improvements in pain symptoms did not 324 
appear to be mediated through reductions in training volume. The findings indicate that 325 
insoles have the potential to provide clinically meaningful improvements in self-reported pain 326 
symptoms in runners with patellofemoral pain classified into the weak and tight subgroup 327 
according to Selfe et al., (2016). However, it should be stressed that the findings from the 328 
current study are specific to the insoles utilized in this investigation and further exploration is 329 
needed using additional insoles before substantial claims can be fully corroborated.   330 
 331 
Of further importance to the current investigation is the observation that peak patellofemoral 332 
force/ stress and the patellofemoral force per mile were significantly attenuated in both 333 
subgroups as a function of the 4-week intervention. Contextualization of these patellofemoral 334 
loading variables showed that whilst large effect sizes were found; much like the alterations 335 
in pain symptoms the reductions only exceeded the MCID in the weak and tight group. 336 
Specifically, excessive patellofemoral joint stress is considered a key mechanism linked to 337 
the aetiology of pain symptoms in active individuals (Ho et al., 2012). Therefore, it is 338 
proposed that the improvements in pain symptoms in the weak and tight subgroup as a 339 
function of the 4-week intervention, may have been mediated as a direct consequence of the 340 
corresponding statistical reductions in patellofemoral loading.  341 
 342 
Further to the above, it is likely that the reductions in patellofemoral loading in the weak and 343 
tight subgroup, were mediated by the corresponding reductions in knee flexion in this group 344 
which also exceeded the MCID. The alterations in knee flexion may be caused by a 345 
proprioceptive effect, facilitated by the shock attenuating properties of the insoles. This 346 
notion is supported by the observations of Sinclair et al., (2015) who found that shock 347 
absorbing insoles produced significant reductions in both knee flexion and patellofemoral 348 
joint loading during running. Furthermore, insoles have also been shown previously to 349 
enhance proprioception through stimulation of cutaneous mechanoreceptors (Yalla et al., 350 
2014). The central nervous system uses ascending motor pathways that receive information 351 
from the feet to control the position of the lower extremities and coordinate movement 352 
(Christovao et al., 2013). However, because proprioception was not examined as part of this 353 
study, further confirmatory analyses are required before this can be substantiated. 354 
Nonetheless, a reduced knee flexion angle may lead to a reduction in the demands on the 355 
knee extensors during the landing phase, thus the loads imposed on the patellofemoral joint 356 
are attenuated (Thomee et al., 1999).  357 
 358 
A further important consideration in relation to the current investigation is the observation 359 
that the integral of the knee adduction moment increased significantly as a function of the 4-360 
week intervention. However, the increases in knee adduction moment integral as a function 361 
of the 4-week intervention showed that only the weak and tight subgroup exceeded the MCID 362 
threshold. This observation supports those of Franz et al., (2008), who found that insoles 363 
significantly increased the knee adduction moment during walking and running. Although the 364 
experimental insoles did not feature any posting, the medial arch support may have 365 
sufficiently shifted the position of the centre of pressure medially across the entirety of the 366 
stance phase to produce a consistent change in the moment arm of the GRF vector relative to 367 
the knee joint centre (Franz et al., 2008). This increases the knee adduction moment integral, 368 
and consequently compressive loading at the medial aspect of the tibiofemoral joint (Kean et 369 
al., (2012). As the medial tibiofemoral compartment is considerably more susceptible to 370 
injury than the lateral aspect (Wise et al., 2012) and tibiofemoral pathologies account for up 371 
to 16.8 % of all knee injuries (Taunton et al., 2002) an increase in knee adduction moment is 372 
an undesirable outcome. Kean et al., (2012) also demonstrated that the integral of the knee 373 
adduction moment was a clinically important predictor of medial radiographic knee 374 
osteoarthritis. Therefore, whilst insoles were effective in reducing patellofemoral symptoms 375 
in the weak and tight subgroup; over time they may increase the risk of medial compartment 376 
knee osteoarthritis in this group. This is a clear and essential avenue for further longitudinal 377 
analyses to investigate the long term efficacy of insoles in runners with knee pathologies. 378 
 379 
A potential drawback to this investigation is that patellofemoral joint kinetics were quantified 380 
via a musculoskeletal modelling approach. This process was necessary due to the 381 
impracticalities and invasive nature of obtaining in vivo measurements of joint kinetics. 382 
However, although the approach utilized in this study represents expansion compared to 383 
preceding mechanisms, in that the model accounted for co-contraction of the knee flexor 384 
musculature, further work is required to improve the efficacy of subject specific knee joint 385 
musculoskeletal models which will make further developments in clinical biomechanics 386 
possible. 387 
 388 
In conclusion, this is the first study to examine pain symptoms, psychological wellbeing and 389 
biomechanical parameters following an intervention using insoles with recreational runners 390 
subgrouped in accordance with Selfe et al. (2016). The findings showed significant 391 
improvements in self-reported pain, psychological wellbeing and patellofemoral loading as a 392 
function of the 4-week intervention. The recreational runners in the study fell into two 393 
subgroups; strong and weak and tight. Although improvements in pain were found in both 394 
groups, only the weak and tight subgroup results were associated with reductions in pain 395 
symptoms that exceeded the MCID. It is proposed that this improvement was mediated 396 
through reductions in patellofemoral stress in this subgroup. The key implication from this 397 
study is that using semi-custom insoles as a conservative management strategy can reduce 398 
pain symptoms in male and female runners associated with the weak and tight subgroup. 399 
Further research including a control group and also runners from the weak and pronated 400 
group is important for advancements in the treatment of patellofemoral pain. 401 
 402 
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 553 
 554 
 555 
51.  Overall Strong Weak and tight 
Table 1: Demographic variables overall and for each subgroup. 556 
 557 
 
Mean SD Mean SD Mean SD 
N 17 11 6 
Age 34.06 10.41 33.64 9.68 34.83 12.59 
Body mass (kg) 72.28 13.02 73.75 13.69 71.03 13.71 
Stature (m) 1.74 0.08 1.75 0.09 1.72 0.07 
BMI (kg/m2) 23.80 2.44 23.74 2.47 23.90 2.61 
10 km time (min: seconds) 47:24 4:16 46:26 4:09 47:19 4:10 
Muscle length Rectus Femoris (˚) 135.83 9.60 134.23 10.29 138.78 8.17 
Muscle Length Gastrocnemius (˚) 66.06 4.19 65.12 4.52 67.78 3.14 
Muscle strength Quadriceps (Nm/kg) 1.38 0.31 1.55 0.20 1.06 0.17 
Muscle strength hip abductors (Nm/kg) 1.41 0.41 1.61 0.35 1.04 0.20 
Patellar mobility (mm) 11.18 1.91 11.73 2.00 10.17 1.33 
Foot posture index 3.12 2.03 3.18 2.14 3.00 2.00 
Table 2: Knee pain and psychological wellbeing parameters as a function of the foot orthoses intervention and subgroup. 558 
Key: A = PRE-POST INTERVENTION main effect 559 
 560 
Table 3: Musculoskeletal loading and temporal parameters as a function of the foot orthoses intervention and subgroup. 561 
 Strong Weak & Tight 
MCID  
 
Pre Post Pre Post 
 
 
Mean SD Mean SD Mean SD Mean SD 
 Peak Patellofemoral force (BW) 3.40 0.75 3.08 0.77 3.68 1.30 2.85 1.11 0.54 A 
Patellofemoral load rate (BW/s) 83.59 18.74 88.63 22.52 103.13 30.18 95.45 35.70 14.83   
Peak patellofemoral Stress (KPa/BW) 6.82 1.66 6.39 1.51 7.66 2.64 6.28 2.59 1.16 A 
Step length (m) 1.31 0.13 1.33 0.10 1.36 0.19 1.38 0.23 0.09 
 
Patellofemoral force per mile (BW·mile) 183.07 42.25 155.15 46.84 189.44 81.54 138.24 63.03 32.44  A 
Peak knee adduction moment (Nm/kg) 0.89 0.32 1.02 0.35 1.02 0.16 1.11 0.28 0.18   
Knee adduction moment integral (Nm/kg·ms) 78.57 35.96 89.97 38.16 76.67 23.50 97.73 28.11 19.69 A 
Knee adduction moment load rate (Nm/kg/s) 54.50 16.80 65.85 25.92 67.85 19.87 76.73 24.09 12.61   
Key: A = PRE-POST INTERVENTION main effect 562 
         563 
Table 4: Knee joint kinematics parameters as a function of the foot orthoses intervention and subgroup. 564 
 Strong Weak & Tight MCID 
 
 Strong Weak & Tight 
MCID 
 
 
Pre Post Pre Post  
 
Mean SD Mean SD Mean SD Mean SD  
KOOS-PT 63.84 9.88 71.49 10.92 53.03 16.86 72.73 7.74 16.40 A 
COOP-WONCA 1.91 0.29 1.55 0.30 2.08 0.23 1.83 0.24 0.16 A 
 
Pre Post Pre Post 
 
 
Mean SD Mean SD Mean SD Mean SD 
 Sagittal plane (+ = flexion)                   
Angle at footstrike (˚) 11.70 3.18 9.25 3.59 16.69 7.96 9.93 7.96 3.13 A 
Peak flexion (˚) 38.86 4.44 36.62 4.99 41.54 10.59 37.64 9.99 3.78 A 
Range of motion (˚) 27.15 3.14 27.37 3.39 24.85 7.00 27.71 8.46 3.04   
Coronal plane (+ = adduction)                    
Angle at footstrike (˚) -3.89 2.79 -3.27 3.12 -2.35 5.16 -2.17 2.94 1.99   
Peak abduction (˚) -9.69 4.94 -9.48 4.98 -7.94 4.63 -9.11 3.75 2.76   
Range of motion (˚) 5.80 3.43 6.21 3.49 5.59 3.58 6.94 2.13 1.92   
Transverse plane (+ = internal)                    
Angle at footstrike (˚) -5.22 10.95 -1.33 6.94 -4.79 9.29 -0.87 6.62 5.04   
Peak internal rotation (˚) 9.71 7.23 11.68 5.18 12.47 6.71 16.26 4.36 3.80   
Range of motion (˚) 14.92 8.48 13.01 4.51 17.26 5.82 17.13 5.31 3.64   
Key: A = PRE-POST INTERVENTION main effect 565 
          566 
 567 
Table 5: Ankle and tibial kinematics as a function of the foot orthoses intervention and subgroup.  568 
 Strong Weak & Tight 
MCID 
 
 
Pre Post Pre Post 
 
 
Mean SD Mean SD Mean SD Mean SD 
 Ankle                   
Sagittal plane (+ = dorsiflexion)                   
Angle at footstrike (˚) 7.55 6.93 6.55 6.31 6.72 6.98 7.53 8.54 4.11   
Peak dorsiflexion (˚) 16.86 4.49 16.80 4.33 19.49 5.90 19.57 6.32 2.94   
Range of motion (˚) 11.29 5.57 11.88 5.31 13.45 4.17 12.74 3.72 2.91   
Coronal plane (+ = inversion)                    
Angle at footstrike (˚) -2.55 5.99 -2.14 5.32 -2.88 9.66 1.14 10.88 4.39   
Peak eversion (˚) -11.79 6.65 -11.21 7.30 -15.55 10.49 -12.49 9.28 4.71   
Range of motion (˚) 9.24 2.08 9.06 3.35 12.67 4.18 13.62 4.35 1.95   
Transverse plane (+ = external)                    
Angle at footstrike (˚) -13.96 3.93 -13.60 3.37 -16.97 5.86 -13.46 5.16 3.54   
Peak external rotation (˚) -4.84 4.80 -5.03 5.37 -6.38 4.83 -1.12 6.24 5.13   
Range of motion (˚) 9.12 2.59 8.57 2.74 10.59 3.42 12.34 3.20 1.79   
Tibial internal rotation (+ = internal)                    
Transverse plane                    
Angle at footstrike (˚) 6.50 5.86 6.33 4.86 7.96 8.79 3.46 9.98 4.08   
Peak tibial internal rotation (˚) 13.11 7.11 12.55 7.18 17.20 11.04 12.89 9.54 4.86   
Range of motion (˚) 6.61 2.34 6.22 3.81 9.24 4.74 9.42 3.94 2.10   
EV/TIR ratio 1.49 0.43 1.74 0.59 1.48 0.28 1.52 0.34 0.27   
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